Citadel Advisors »

Matinas Biopharma Hldgs shares owned by Citadel Advisors

Quarter-by-quarter ownership of Matinas Biopharma Hldgs (MTNB) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Matinas Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Matinas Biopharma Hldgs held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Matinas Biopharma Hldgs by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $39k 66k 0.59

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Advanced Micro Devices Call Option (AMD)

View all positions for Citadel Advisors

Top funds holding Matinas Biopharma Hldgs

Citadel Advisors
Vanguard Group
Geode Capital Management
BlackRock
DRW Holdings
Holos Integrated Wealth
Renaissance Technologies
Susquehanna International
XTX Topco
Jane Street
Virtu Financial
State Street Corporation
Sargent Investment Group
Tower Research Capital
UBS Group

View all funds holding Matinas Biopharma Hldgs